VALO OPAL COMPUTATIONAL PLATFORM
DEAD

Serial Number

90181491

Owner

VALO HEALTH, LLC

Attorney

Allison Strickland Ricketts

Filing Date

Sep 15, 2020

Add to watchlist:

No watchlists yet
View on USPTO

VALO OPAL COMPUTATIONAL PLATFORM Trademark

Serial Number: 90181491

VALO OPAL COMPUTATIONAL PLATFORM is a trademark filed by VALO HEALTH, LLC on September 15, 2020. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

VALO HEALTH, LLC (7 trademarks)

75 Hayden Avenue
Lexington, MA 02421

Entity Type: 16

Trademark Details

Filing Date

September 15, 2020

Registration Date

Not Registered

Goods & Services

downloadable and recorded software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; downloadable and recorded software for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; downloadable and recorded software for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement

Research and development in the field of drug discovery and development, computational biology, bioinformatics, and genomics; technical scientific consultation and product development for others in the fields of drug discovery and development, pharmaceuticals, biotechnology and immunology; software as a service for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; software as a service for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; software as a service for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement; consulting in the fields of drug discovery and development, clinical trial management and patient engagement in drug clinical trials

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jul 29, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 29, 2024 ABN2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 12, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 12, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 12, 2024 COAR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Mar 28, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Mar 28, 2024 XELR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Jan 6, 2024 GNS1
SUBSEQUENT FINAL EMAILED
Jan 6, 2024 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Jan 6, 2024 CFRC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 14, 2023 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 24, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 24, 2023 GNSL
SUSPENSION LETTER WRITTEN
Mar 24, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 23, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 22, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 22, 2023 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 4, 2023 GNFN
FINAL REFUSAL E-MAILED
Jan 4, 2023 GNFR
FINAL REFUSAL WRITTEN
Jan 4, 2023 CNFR
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 5, 2022 RCCK
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 8, 2022 ERSI
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 25, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 25, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 25, 2022 REAP
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 29, 2022 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 25, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 25, 2021 GNSL
SUSPENSION LETTER WRITTEN
Aug 25, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 27, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 26, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 26, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 11, 2021 GNRN
NON-FINAL ACTION E-MAILED
Feb 11, 2021 GNRT
NON-FINAL ACTION WRITTEN
Feb 11, 2021 CNRT
ASSIGNED TO EXAMINER
Jan 27, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 21, 2020 NWOS